A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling.

Saved in:
Bibliographic Details
Title: A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling.
Authors: Dolan M; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Shi Y; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Mastri M; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Long MD; Department of Bioinformatics and Statistics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., McKenery A; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Hill JW; Jacobs School of Medicine and Biomedical Sciences, SUNY at Buffalo, Buffalo, New York., Vaghi C; Inria Team MONC, Inria Bordeaux Sud-Ouest, Talence, France.; Computational Pharmacology and Clinical Oncology (COMPO), Inria Sophia Antipolis-Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France., Benzekry S; Inria Team MONC, Inria Bordeaux Sud-Ouest, Talence, France.; Computational Pharmacology and Clinical Oncology (COMPO), Inria Sophia Antipolis-Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France., Barbi J; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Ebos JML; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2024 Sep 04; Vol. 23 (9), pp. 1241-1260.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first